Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Tyagarajan Seshu. Director active across 1 company, notably Candel Therapeutics, Inc.. Aggregated, 14 reports have been logged. Split: 1 buy · 8 sells. Total volume traded: €796k. History available since 28 November 2022. The latest transaction was disclosed on 17 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Tyagarajan Seshu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Tyagarajan Seshu is a declarant linked to Candel Therapeutics, Inc. (XNAS), where he is Chief Technology Officer. He has 13 filings in total, and across the 13 recent filings held in the sample, the transactions show EUR 4,822 of purchases and EUR 718,579 of sales between 2022-11-30 and 2026-07-01, with Cession as the modal transaction nature.